Average Co-Inventor Count = 12.06
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Exelixis, Inc. (14 from 175 patents)
2. Symphony Evolution, Inc. (4 from 10 patents)
3. Other (1 from 832,843 patents)
19 patents:
1. 11597699 - MEK inhibitors and methods of their use
2. 10266518 - Solid dosage formulations of substituted quinazoline receptor-type kinase modulators and methods of use thereof
3. 9796704 - Substituted quinazolines as receptor-type kinase inhibitors
4. 9359332 - Processes for the preparation of substituted quinazolines
5. 8697737 - Raf modulators and methods of use
6. 8658654 - Receptor-type kinase modulators and methods of use
7. 8648066 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
8. 8637499 - Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture
9. 8372851 - Pyrazolo pyrimidines as casein kinase II (CK2) modulators
10. 8362002 - Azetidines as MEK inhibitors for the treatment of proliferative diseases
11. 8101625 - Pyrimidinones as Casein Kinase II (CK2) modulators
12. 8076338 - Kinase modulators and methods of use
13. 8012956 - Tropane compounds
14. 7994172 - [1H-pyrazolo[3, 4-D]pyrimidin-4-yl]-piperidine or -piperazine compounds as serine-theoronine kinase modulators (P70s6k, Atk1 and Atk2) for the treatment of immunological, inflammatory and proliferative diseases
15. 7915250 - Azetidines as MEK inhibitors for the treatment of proliferative diseases